Log in

Extraction Oil & Gas Stock Forecast, Price & News

-0.02 (-3.73 %)
(As of 10/23/2020 03:57 PM ET)
Today's Range
Now: $0.40
50-Day Range
MA: $0.31
52-Week Range
Now: $0.40
Volume33,325 shs
Average Volume183,345 shs
Market Capitalization$7.15 million
P/E RatioN/A
Dividend YieldN/A
VIVUS, Inc. operates as a specialty pharmaceutical company primarily in the United States and the European Union. The company offers Qsymia for the treatment of obesity as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body-mass index of 30 or greater (obese patients) or 27 or greater (overweight patients) in the presence of at least one weight-related comorbidity, such as hypertension, type 2 diabetes mellitus, or high cholesterol. It also provides PANCREAZE to treat exocrine pancreatic insufficiency due to cystic fibrosis, chronic pancreatitis, pancreatic cancer or other conditions; and STENDRA/SPEDRA, an oral phosphodiesterase type 5 inhibitor for erectile dysfunction. In addition, the company is developing Qsymia, which has completed Phase II clinical study for treating various diseases, including obstructive sleep apnea, diabetes, nonalcoholic steatohepatitis, and bariatric surgery; and VI-0106 that has completed Phase IIa study to treat patients with pulmonary arterial hypertension. It has collaboration agreements with Mitsubishi Tanabe Pharma Corporation; Menarini Group; Sanofi; Metuchen Pharmaceuticals, LLC; Selten Pharma, Inc.; and Alvogen Malta Operations (ROW) Ltd. VIVUS, Inc. was founded in 1991 and is headquartered in Campbell, California. On July 7, 2020, VIVUS, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.63 out of 5 stars

Industry, Sector and Symbol

Industry Pharmaceutical preparations



Sales & Book Value

Annual Sales$69.76 million
Book Value($6.50) per share


Net Income$-31,500,000.00


Market Cap$7.15 million
Next Earnings Date11/3/2020 (Estimated)
-0.02 (-3.73 %)
(As of 10/23/2020 03:57 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive VVUSQ News and Ratings via Email

Sign-up to receive the latest news and ratings for VVUSQ and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Extraction Oil & Gas (OTCMKTS:VVUSQ) Frequently Asked Questions

When is Extraction Oil & Gas' next earnings date?

Extraction Oil & Gas is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Extraction Oil & Gas

Are investors shorting Extraction Oil & Gas?

Extraction Oil & Gas saw a decrease in short interest in the month of September. As of September 30th, there was short interest totaling 52,800 shares, a decrease of 34.7% from the September 15th total of 80,800 shares. Based on an average daily volume of 626,000 shares, the days-to-cover ratio is presently 0.1 days.
View Extraction Oil & Gas' Short Interest

Who are some of Extraction Oil & Gas' key competitors?

Who are Extraction Oil & Gas' key executives?

Extraction Oil & Gas' management team includes the following people:
  • Mr. John P. Amos, CEO, Pres & Director (Age 53, Pay $556.2k)
  • Mr. Mark K. Oki, Sr. VP, CFO & Chief Accounting Officer (Age 51, Pay $422.2k)
  • Mr. John L. Slebir, Sr. VP of Bus. Devel., Gen. Counsel & Sec. (Age 55, Pay $632.7k)
  • Dr. Santosh T. Varghese, Sr. VP & Chief Medical Officer (Age 50, Pay $555.44k)
  • Ms. Deborah Larsen, Chief Strategy Officer - Commercial Operations

What is Extraction Oil & Gas' stock symbol?

Extraction Oil & Gas trades on the OTCMKTS under the ticker symbol "VVUSQ."

How do I buy shares of Extraction Oil & Gas?

Shares of VVUSQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Extraction Oil & Gas' stock price today?

One share of VVUSQ stock can currently be purchased for approximately $0.40.

How big of a company is Extraction Oil & Gas?

Extraction Oil & Gas has a market capitalization of $7.15 million and generates $69.76 million in revenue each year. The company earns $-31,500,000.00 in net income (profit) each year or ($2.96) on an earnings per share basis. Extraction Oil & Gas employs 59 workers across the globe.

What is Extraction Oil & Gas' official website?

The official website for Extraction Oil & Gas is www.vivus.com.

How can I contact Extraction Oil & Gas?

Extraction Oil & Gas' mailing address is 900 E. HAMILTON AVENUE SUITE 550, CAMPBELL CA, 95008. The company can be reached via phone at 650-934-5200 or via email at [email protected]

This page was last updated on 10/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.